{
    "organizations": [],
    "uuid": "7b118841975ea455627642f14b7fe63084431dd9",
    "author": "",
    "url": "https://www.reuters.com/article/brief-great-point-partners-opposes-biocr/brief-great-point-partners-opposes-biocryst-pharma-proposed-merger-with-idera-pharma-idUSFWN1Q61F4",
    "ord_in_thread": 0,
    "title": "BRIEF-Great Point Partners Opposes Biocryst Pharma Proposed Merger With Idera Pharma",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 16, 2018 / 7:36 PM / Updated 8 minutes ago BRIEF-Great Point Partners Opposes Biocryst Pharma Proposed Merger With Idera Pharma Reuters Staff Feb 16 (Reuters) - Great Point Partners LLC: * GREAT POINT PARTNERS LLC OPPOSES THE BIOCRYST PHARMACEUTICAL PROPOSED MERGER WITH IDERA PHARMACEUTICALS, INC. * ‍GREAT POINT PARTNERS, LLC SAYS BENEFICIALLY OWNING ABOUT 7.5 MILLION SHARES OF COMMON STOCK OF BIOCRYST PHARMACEUTICALS​ * GREAT POINT PARTNERS SAYS BELIEVE BIOCRYST PHARMA‘S SHARES ARE “UNDERVALUED” * GREAT POINT PARTNERS SAYS BELIEVE IT IS “INCUMBENT” UPON BIOCRYST PHARMACEUTICAL BOARD TO EXPLORE ALTERNATIVE STRATEGIES Source text for Eikon: Further company coverage:",
    "published": "2018-02-16T21:33:00.000+02:00",
    "crawled": "2018-02-16T21:52:50.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "updated",
        "minute",
        "ago",
        "point",
        "partner",
        "opposes",
        "biocryst",
        "pharma",
        "proposed",
        "merger",
        "idera",
        "pharma",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "great",
        "point",
        "partner",
        "llc",
        "great",
        "point",
        "partner",
        "llc",
        "opposes",
        "biocryst",
        "pharmaceutical",
        "proposed",
        "merger",
        "idera",
        "pharmaceutical",
        "point",
        "partner",
        "llc",
        "say",
        "beneficially",
        "owning",
        "million",
        "share",
        "common",
        "stock",
        "biocryst",
        "great",
        "point",
        "partner",
        "say",
        "believe",
        "biocryst",
        "pharma",
        "share",
        "undervalued",
        "great",
        "point",
        "partner",
        "say",
        "believe",
        "incumbent",
        "upon",
        "biocryst",
        "pharmaceutical",
        "board",
        "explore",
        "alternative",
        "strategy",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}